238 related articles for article (PubMed ID: 70536)
1. Stimulation of tumor cell growth in vitro: a critical evaluation of immunologic specificity.
Lamon EW
J Natl Cancer Inst; 1977 Sep; 59(3):769-74. PubMed ID: 70536
[No Abstract] [Full Text] [Related]
2. Cytotoxicity against tumour-associated antigens not H-2 restricted.
Holden HT; Herberman RB
Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
[No Abstract] [Full Text] [Related]
3. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
[No Abstract] [Full Text] [Related]
4. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus.
Jones JM; Jensen F; Veit B; Feldman JD
J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500
[No Abstract] [Full Text] [Related]
5. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
Plata F; Jongeneel CV
J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
[No Abstract] [Full Text] [Related]
6. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
8. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
Glaser M
J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
[No Abstract] [Full Text] [Related]
9. Antitumour activity in vitro dependent on immune B lymphocytes.
Lamon EW; Wigzell H; Andersson B; Klein E
Nat New Biol; 1973 Aug; 244(137):209-11. PubMed ID: 4542206
[No Abstract] [Full Text] [Related]
10. Blocking of syngeneic effector T cells by soluble tumour antigens.
Plata F; Levy JP
Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
[No Abstract] [Full Text] [Related]
11. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours.
Gomard E; Duprez V; Henin Y; Levy JP
J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated cytotoxicity to moloney sarcoma in syngeneic and allogeneic rats.
Veit BC; Feldman JD
Int J Cancer; 1975 Mar; 15(3):367-76. PubMed ID: 1079791
[TBL] [Abstract][Full Text] [Related]
13. Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus.
Herberman RB; Nunn ME; Lavrin DH; Asofsky R
J Natl Cancer Inst; 1973 Nov; 51(5):1509-12. PubMed ID: 4543478
[No Abstract] [Full Text] [Related]
14. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
Lamon EW; Skurzak HM; Klein E; Wigzell H
J Exp Med; 1972 Nov; 136(5):1072-9. PubMed ID: 4117188
[No Abstract] [Full Text] [Related]
15. Central problems in tumor immunology, 1976.
Weiss DW
Isr J Med Sci; 1976; 12(4-5):281-7. PubMed ID: 1084878
[No Abstract] [Full Text] [Related]
16. Immune response to polyoma tumor cells in mice. I. Magnitude and specificity of the in vitro cellular cytotoxicity elicited by immunization with graded numbers of tumor cells.
Walia AS; Lamon EW
J Natl Cancer Inst; 1977 Jun; 58(6):1671-5. PubMed ID: 194042
[No Abstract] [Full Text] [Related]
17. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
Tamerius JD; Hellström I
J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
[No Abstract] [Full Text] [Related]
18. Embryonic antigens in tumor immunity.
Della Porta G
Johns Hopkins Med J Suppl; 1974; 3():279-87. PubMed ID: 4138923
[No Abstract] [Full Text] [Related]
19. Specific killing of tumor cells in vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens.
Pollack S; Heppner G; Brawn RJ; Nelson K
Int J Cancer; 1972 Mar; 9(2):316-23. PubMed ID: 5041610
[No Abstract] [Full Text] [Related]
20. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
Halliday WJ; Koppi TA; McKenzie IF
J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
